DE60328212D1 - Verfahren zur herstellung von alpha herpes virus resistenten säugetieren, mit diesem verfahren hergestellte säugetiere sowie ihre nachkommen - Google Patents

Verfahren zur herstellung von alpha herpes virus resistenten säugetieren, mit diesem verfahren hergestellte säugetiere sowie ihre nachkommen

Info

Publication number
DE60328212D1
DE60328212D1 DE60328212T DE60328212T DE60328212D1 DE 60328212 D1 DE60328212 D1 DE 60328212D1 DE 60328212 T DE60328212 T DE 60328212T DE 60328212 T DE60328212 T DE 60328212T DE 60328212 D1 DE60328212 D1 DE 60328212D1
Authority
DE
Germany
Prior art keywords
mammals
herpes virus
success
manufactured
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60328212T
Other languages
English (en)
Inventor
Ono Etsuro
Uede Toshimitsu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FRANCE HYBRIDES
Original Assignee
FRANCE HYBRIDES
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FRANCE HYBRIDES filed Critical FRANCE HYBRIDES
Application granted granted Critical
Publication of DE60328212D1 publication Critical patent/DE60328212D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027New or modified breeds of vertebrates
    • A01K67/0275Genetically modified vertebrates, e.g. transgenic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503Immunoglobulin superfamily
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00Animals characterised by species
    • A01K2227/10Mammal
    • A01K2227/108Swine
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00Animals characterised by purpose
    • A01K2267/02Animal zootechnically ameliorated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/30Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Environmental Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE60328212T 2002-10-15 2003-10-14 Verfahren zur herstellung von alpha herpes virus resistenten säugetieren, mit diesem verfahren hergestellte säugetiere sowie ihre nachkommen Expired - Fee Related DE60328212D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0212775A FR2845692A1 (fr) 2002-10-15 2002-10-15 Procede pour produire un mammifere rendu resistant a une infection par un alpha herpes virus par transgenese germinale ainsi que mammifere obtenu par la mise en oeuvre de ce procede
PCT/FR2003/003024 WO2004035775A2 (fr) 2002-10-15 2003-10-14 Procede pour produire un mammifere rendu resistant a une infection par un alpha herpes virus ainsi que mammifere obtenu par la mise en oeuvre de ce procede et descendant d'un tel mammifere

Publications (1)

Publication Number Publication Date
DE60328212D1 true DE60328212D1 (de) 2009-08-13

Family

ID=32039728

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60328212T Expired - Fee Related DE60328212D1 (de) 2002-10-15 2003-10-14 Verfahren zur herstellung von alpha herpes virus resistenten säugetieren, mit diesem verfahren hergestellte säugetiere sowie ihre nachkommen

Country Status (11)

Country Link
US (1) US20060272040A1 (de)
EP (1) EP1551222B1 (de)
CN (1) CN1705436A (de)
AT (1) ATE434933T1 (de)
AU (1) AU2003288321A1 (de)
BR (1) BR0315394A (de)
CA (1) CA2501340A1 (de)
DE (1) DE60328212D1 (de)
FR (1) FR2845692A1 (de)
MX (1) MXPA05003322A (de)
WO (1) WO2004035775A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102676580B (zh) * 2012-05-30 2013-06-19 扬州大学 高免疫原性单纯疱疹病毒gG1转基因花生的制备方法
CN105251000B (zh) * 2014-09-30 2018-12-14 普莱柯生物工程股份有限公司 猪伪狂犬病病毒疫苗组合物及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5866755A (en) * 1993-06-14 1999-02-02 Basf Aktiengellschaft Animals transgenic for a tetracycline-regulated transcriptional inhibitor
US6291207B1 (en) * 1995-07-28 2001-09-18 Northwestern University Herpes virus entry receptor protein
EP0948543A1 (de) * 1996-12-12 1999-10-13 Genentech, Inc. Hemv-polyptide und ihre verwendung
EP1002864A1 (de) * 1998-11-10 2000-05-24 Universita' degli studi di Bologna HIgR und relatierte V Domäne zur Herstellung eines Arzneimittels zur Vorbeugung oder Behandlung von HSV-1, HSV-2 und BHV Infektionen
WO2001079496A2 (en) * 2000-03-13 2001-10-25 La Jolla Institute For Allergy And Immunology Ligand for herpes simplex virus entry mediator and methods of use
JP2004528008A (ja) * 2000-10-05 2004-09-16 イミュネックス・コーポレーション ネクチンポリペプチド、ポリヌクレオチド、該ポリペプチドおよびポリヌクレオチドを作成し、そして使用する方法

Also Published As

Publication number Publication date
MXPA05003322A (es) 2006-02-10
WO2004035775A3 (fr) 2004-06-17
EP1551222B1 (de) 2009-07-01
AU2003288321A8 (en) 2004-05-04
FR2845692A1 (fr) 2004-04-16
EP1551222A2 (de) 2005-07-13
AU2003288321A1 (en) 2004-05-04
CN1705436A (zh) 2005-12-07
US20060272040A1 (en) 2006-11-30
ATE434933T1 (de) 2009-07-15
WO2004035775A2 (fr) 2004-04-29
BR0315394A (pt) 2005-10-11
CA2501340A1 (fr) 2004-04-29

Similar Documents

Publication Publication Date Title
DK0918848T3 (da) Fremgangsmåder til at behandle kræftsygdomme og patogene infektioner ved anvendelse af antigenpræsenterende celler påfyldt med RNA
ATE378403T1 (de) Transchromosomale transgen-nagetiere zur herstellung von humänen antikörpern
ATE459578T1 (de) Entsalzungsschiff sowie verfahren zur herstellung von entsalztem wasser
MY148081A (en) Cultivated agarwood
DE69621467D1 (de) Vorbereitung von cu x in y ga z se n (x=0-2, y = 0-2, z = 0-2, n = 0-3) vorläuferfilmen durch elektroplattierung zur herstellung von solarzellen von hohem wirkungsgrad
DE50312217D1 (de) Verfahren zur herstellung von 1-olefinen durch katalytische spaltung von 1-alkoxyalkanen
ATE340857T1 (de) Verfahren zur herstellung von l-aminosäuren durch erhöhung des zellulären nadph
WO2004016742A3 (en) α(1,3)-GALACTOSYLTRANSFERASE NULL CELLS, METHODS OF SELECTING AND α(1,3)-GALACTOSYLTRANSFERASE NULL SWINE PRODUCED THEREFROM
DK0972445T3 (da) Kimærisk mus som udtrykker et humant antistof
DE69942488D1 (de) Verfahren zur herstellung von l-arabinose durch saure hydrolyse
WO2002010337A3 (en) Method of cloning porcine animals
ATE281516T1 (de) Verfahren zur herstellung von säugetieren mit definierten genetischen eigenschaften
WO2001050848A3 (en) Clonal propagation of primate offspring by embryo splitting
DE69604087T2 (de) Verfahren zur herstellung von einer hyaluronsäurefraktion mit niedrigem polydispersionindex
DE69522436T2 (de) Verfahren zur herstellung von äthylalkohol
DE50113420D1 (de) Verfahren zur herstellung einer solarzelle und nach diesem verfahren hergestellte solarzelle
DE69737996D1 (de) Methoden zur herstellung von nukleotidintegrasen
WO2000026357A3 (en) Transgenic and cloned mammals
DE60328212D1 (de) Verfahren zur herstellung von alpha herpes virus resistenten säugetieren, mit diesem verfahren hergestellte säugetiere sowie ihre nachkommen
ATE362523T1 (de) Fermentiertes getränk aus bierwürze, sowie verfahren zur herstellung
ATE531805T1 (de) Transgene ananaspflanzen mit modifiziertem carotinoidgehalt und verfahren zu ihrer herstellung
DE3580611D1 (de) Verfahren zur herstellung alkoholischer getraenke.
DE68907608T2 (de) Verfahren zur herstellung von lignin-peroxidase durch verwendung von nichtproliferierenden phanerochaete chryosporium-zellen.
DE590096T1 (de) Verfahren zur herstellung optisch aktiver cyanhydrine durch enzyme.
ATE377943T1 (de) Verfahren zur züchtung von nicht-menschliche säugertieren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee